The 20 Best Scleredema Doctors in The United States

David Mael is a Rheumatologist in Chicago, Illinois. Dr. Mael is rated as an Experienced provider by MediFind in the treatment of Scleredema. His top areas of expertise are Rheumatoid Arthritis (RA), Necrotizing Vasculitis, Postmenopausal Osteoporosis, and Osteoporosis.

Katina Tsagaris is a Rheumatologist in Atlanta, Georgia. Dr. Tsagaris has been practicing medicine for over 17 years and is rated as a Distinguished provider by MediFind in the treatment of Scleredema. Her top areas of expertise are Scleredema, Systemic Sclerosis (SSc), Scleroma, and Scleroderma.

David Alter is a primary care provider, practicing in Internal Medicine in Oak Lawn, Illinois. Dr. Alter is rated as an Advanced provider by MediFind in the treatment of Scleredema. His top areas of expertise are Scleredema, Ascites, Type 2 Diabetes (T2D), and Gallbladder Removal.

Joseph Shanahan is a Rheumatologist in Raleigh, North Carolina. Dr. Shanahan has been practicing medicine for over 29 years and is rated as a Distinguished provider by MediFind in the treatment of Scleredema. His top areas of expertise are Scleredema, Scleroma, Systemic Sclerosis (SSc), and Psoriasis.

. Dr. Emkey is rated as an Experienced provider by MediFind in the treatment of Scleredema. His top areas of expertise are Osteoporosis, Postmenopausal Osteoporosis, Rheumatoid Arthritis (RA), and Psoriasis.

. Dr. Lvovich is rated as an Experienced provider by MediFind in the treatment of Scleredema. Her top areas of expertise are Juvenile Dermatomyositis, Juvenile Idiopathic Arthritis (JIA), Henoch-Schonlein Purpura, and Dermatomyositis.

Dr. Bernstein's clinical and research interests focus on systemic sclerosis (scleroderma), as well as on the detection and treatment of interstitial lung disease and pulmonary hypertension in patients with autoimmune diseases. She is the Florence Irving Associate Professor of Medicine at Columbia University Vagelos College of Physicians and Surgeons and an Associate Attending at NewYork-Presbyterian Hospital. Dr. Bernstein is the founder and Director of the Columbia University/NewYork-Presbyterian Scleroderma Center.Dr. Bernstein graduated summa cum laude from Amherst College, and was inducted into the Alpha Omega Alpha medical honor society while a medical student at the Mount Sinai School of Medicine. She was the recipient of the American College of Rheumatology Distinguished Fellow Award and the Charles L. Christian Award for Excellence in Musculoskeletal Research while a rheumatology fellow at Hospital for Special Surgery. In recognition of her outstanding contributions to systemic sclerosis research, Dr. Bernstein received the Edith Busch Prize for Young Investigators at the 8th Systemic Sclerosis World Congress. Dr. Bernstein has received grants from the National Institutes of Health, Department of Defense, Arthritis Foundation, and Rheumatology Research Foundation to study lung disease in scleroderma. Her ongoing research projects focus on interstitial lung disease in scleroderma and on lung transplantation in patients with autoimmune diseases. Dr. Bernstein is rated as a Distinguished provider by MediFind in the treatment of Scleredema. Her top areas of expertise are Systemic Sclerosis (SSc), Scleroderma, Scleredema, and Scleroma.

Robert Lafyatis, MD, is a rheumatologist and is certified in rheumatology by the American Board of Internal Medicine. He is  the Thomas Medsger Professor of Medicine at the University of Pittsburgh School of Medicine. He received his medical degree from University of Cincinnati and completed his residency at Wake Forest School of Medicine, followed by his fellowship at National Institutes of Health.Dr. Lafyatis’s clinical interests include systemic sclerosis (scleroderma) and its complications in the skin and lungs. His research interests include understanding the underlying cause of scleroderma and finding new treatments. Dr. Lafyatis directs the University of Pittsburgh/University of Pittsburgh Medical Center Scleroderma Center and the National Institutes of Health, Center for Scleroderma Research Translation.  He has over 200 peer-reviewed publications and co-authors the Textbook of Rheumatology chapter on Scleroderma Pathogenesis. Dr. Lafyatis is rated as an Advanced provider by MediFind in the treatment of Scleredema. His top areas of expertise are Systemic Sclerosis (SSc), Scleroderma, Pulmonary Fibrosis, Scleroma, and Pancreaticoduodenectomy.

Soumya Chatterjee is a Rheumatologist in Cleveland, Ohio. Dr. Chatterjee is rated as an Advanced provider by MediFind in the treatment of Scleredema. His top areas of expertise are Scleroderma, Systemic Sclerosis (SSc), Scleroma, and Sjogren Syndrome.

Laura Hummers is an Associate Professor of Medicine in the Division of Rheumatology. She graduated from the University of Rochester School of Medicine and trained in internal medicine at Thomas Jefferson University. She then pursued her rheumatology fellowship at Johns Hopkins University and has since been on the faculty working at the Johns Hopkins Scleroderma Center since 2003 where she has been Co-Director of the Center. She received her ScM degree through the Graduate Training Program in Clinical Investigation from the Bloomberg School of Public Health in 2010. Dr. Hummers also serves as Clinical Director for the Division of Rheumatology. Dr. Hummers actively participates in a number of clinical trials and clinical investigations at the Scleroderma Center and has a particular interest in predictors of outcomes in scleroderma. She actively manages a large patient practice focused exclusively on scleroderma and related conditions at Johns Hopkins and actively helps to manage the Johns Hopkins Scleroderma Center longitudinal database. She also has specific expertise in other scleroderma-like conditions such as scleromyxedema, scleredema and eosinophilic fasciitis. Dr. Hummers is rated as an Advanced provider by MediFind in the treatment of Scleredema. Her top areas of expertise are Scleroderma, Systemic Sclerosis (SSc), Eosinophilic Fasciitis, and Scleroma.

Jonathan Thomas is a Rheumatologist in Texarkana, Texas. Dr. Thomas is rated as an Advanced provider by MediFind in the treatment of Scleredema. His top areas of expertise are Eosinophilia-Myalgia Syndrome, Antisynthetase Syndrome, Rheumatoid Arthritis (RA), and Sjogren Syndrome.

Su Yin, MD, specializes in rheumatology with expertise in rheumatoid arthritis, lupus, gout and psoriatic arthritis. Dr. Yin enjoys building lifelong relationships with her patients and being able to explain treatment options in a way that allows them to move forward confidently with a plan of care.Away from work, Dr. Yin spends her time being a mom to her two young children. She also enjoys traveling, cooking and gardening. Dr. Yin is rated as an Advanced provider by MediFind in the treatment of Scleredema. Her top areas of expertise are Rheumatoid Arthritis (RA), Psoriatic Arthritis, Rheumatoid Pneumoconiosis, and Rheumatoid Lung Disease.

Duncan Moore is a Rheumatologist in Chicago, Illinois. Dr. Moore has been practicing medicine for over 11 years and is rated as an Advanced provider by MediFind in the treatment of Scleredema. His top areas of expertise are Systemic Sclerosis (SSc), Scleroderma, Scleroma, and Scleredema.

Dr. Ami Shah is an Associate Professor of Medicine and Director of the Division of Rheumatology at the Johns Hopkins University School of Medicine. Dr. Shah also serves as the Co-Director of the Johns Hopkins Scleroderma Center. Her areas of clinical expertise include rheumatology, particularly scleroderma and Raynaud's phenomenon. She is a graduate of the Massachusetts Institute of Technology and Johns Hopkins University School of Medicine. She completed her internal medicine residency training at Stanford University Hospital & Clinics and rheumatology post-doctoral fellowship at Johns Hopkins. During her fellowship training, she earned her Master of Health Science in Clinical Investigation at the Johns Hopkins Bloomberg School of Public Health. Dr. Shah’s clinical practice is focused on the broad spectrum of patients with scleroderma and related disorders, and her expertise includes management of complications such as Raynaud’s phenomenon, digital ischemia, pulmonary hypertension, cardiac dysfunction, myopathy, aggressive skin disease and concomitant cancer. Dr. Shah teaches post-doctoral fellows in her clinic about the evaluation and management of scleroderma. Dr. Shah’s research program has focused on the interface between cancer and autoimmunity in scleroderma, myositis and the newly emerging area of immune-related adverse events due to immune checkpoint inhibitor therapy. In highly collaborative studies, her group has published seminal observations linking cancer with the development of autoimmunity in scleroderma, with implications for cancer screening strategies in this population and the potential to shed insight into the pathogenesis of paraneoplastic rheumatic disease. In addition to her work in cancer and autoimmunity, Dr. Shah has an active research program in other clinical and therapeutic aspects of scleroderma, including early detection of cardiopulmonary complications and improving outcome measures and therapeutics for Raynaud's phenomenon. Dr. Shah also directs rheumatology precision medicine initiatives through the Johns Hopkins Individualized Health (inHealth) Initiative. The division’s program seeks to harness technological resources for comprehensive data collection and harmonization, strengthen novel data analytic approaches including defining unique patient subgroups, and accelerate the incorporation of discoveries into the delivery of clinical care. Dr. Shah has been a recipient of the ACR Research and Education Foundation Clinical Investigator Fellowship Award. In 2018, her research contributions were recognized at the 5th Systemic Sclerosis World Congress with receipt of the Edith Busch Prize for Young Investigators. In 2020, she was honored to receive the prestigious Henry Kunkel Young Investigator Award from the American College of Rheumatology. She is a member of the American College of Rheumatology. Dr. Shah is rated as an Advanced provider by MediFind in the treatment of Scleredema. Her top areas of expertise are Scleroderma, Scleroma, Systemic Sclerosis (SSc), and Scleredema.

Robert Spiera is a Rheumatologist in New York, New York. Dr. Spiera is rated as a Distinguished provider by MediFind in the treatment of Scleredema. His top areas of expertise are Systemic Sclerosis (SSc), Vasculitis, Rhizomelic Pseudopolyarthritis, and Polymyalgia Rheumatica.

Daniel Furst is a Rheumatologist in Los Angeles, California. Dr. Furst is rated as a Distinguished provider by MediFind in the treatment of Scleredema. His top areas of expertise are Systemic Sclerosis (SSc), Scleroderma, Rheumatoid Arthritis (RA), and Arthritis.

Juan Maya is a Rheumatologist in Lake Worth, Florida. Dr. Maya is rated as a Distinguished provider by MediFind in the treatment of Scleredema. His top areas of expertise are Scleredema, Rheumatoid Arthritis (RA), Polymyositis, and Fibromyalgia.

Vivek Nagaraja is a Geriatrics provider in Ann Arbor, Michigan. Dr. Nagaraja is rated as a Distinguished provider by MediFind in the treatment of Scleredema. His top areas of expertise are Scleroderma, Systemic Sclerosis (SSc), Scleroma, and Scleredema.

Lee Shapiro is an Internal Medicine provider in Ballston Spa, New York. Dr. Shapiro is rated as a Distinguished provider by MediFind in the treatment of Scleredema. His top areas of expertise are Scleroderma, Systemic Sclerosis (SSc), Scleroma, and Scleredema.

Nicole Walton is an Internal Medicine provider in Pascagoula, Mississippi. Dr. Walton is rated as a Distinguished provider by MediFind in the treatment of Scleredema. Her top areas of expertise are Rheumatoid Arthritis (RA), Scleredema, Cutaneous Lupus Erythematosus (CLE), Mixed Connective Tissue Disease, and Knee Replacement.